Shellac microcapsule formulations and compositions for topical intestinal delivery of vitamin b3
EP3107553A1
Methods and compositions for intestinal microenvironment transfer
CN105813644A
A pharmaceutical composition containing combinations of nicotinamide and 5-aminosalicylic acid for beneficially influencing the intestinal microbiota and/or treating gastrointestinal inflammation
EP3031486A1
Medication cartridges for optimised dosing
EP2884282A1
Use of tryptophan as a biomarker for patient selection, dosing and therapy monitoring for pharmaceutical compositions targeting the intestinal microbiota in diseases featuring tryptophan deficiency
EP2050759A1
Soluble gp 130 muteins with improved binding activity
KR20140107702A
IMPROVED sgp130Fc DIMERS
EP1873166A1
Improved sgp 130Fc dimers
EP1801121A1
Soluble gp130 molecule variants useful as a medicament
EP1702622A1
Soluble BTNL2 protein useful to inhibit inflammatory disorders
EP1630232A1
Optimized nucleotide sequences encoding sgp130
EP1516627A1
Interferon-Gamma for the treatment of diseases associated with the NOD2 gene
EP1491554A1
PEGylated soluble gp130-dimers useful as a medicament
EP1462527A1
Novel markers for inflammatory bowel disease
EP1148065A1
Fusion proteins comprising two soluble gp130 molecules
